Sanofi/Regeneron’s Dupixent Performance in Eosinophilic Esophagitis is Paving the Way for Future Therapies in an Underserved and Growing Market, According to Spherix Global Insights
Spherix’s tracking data reveals use of Dupixent in EoE has tripled since its approval. Exton, PA., April 3, 2023 –...